New KFF Poll Examines Patterns of Belief Across Common Vaccine Myths — The Monitor

• by Joel Luther, Hagere Yilma, Irving Washington

• July 9, 2026

Incidence of Recurrent Invasive Pneumococcal Disease in Canada

• by Leah J. Ricketson, Altynay Shigayeva, Irina Rajakumar, Zoe Zhong, Kazi Hassan, Irene Martin, Alyssa Golden, Allison J. McGeer, James D. Kellner, Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network, Chingiz Amirov, Neil Rau, Danny Chen, Jeff Powis, Amna Faheem, Kevin Katz, Valerie Sales, Samir Patel, Abdelbaset Belhaj, Reena Lovinsky, David Rose, Christie Vermeiren, Tony Mazzulli, Jennie Johnstone, Karen Green, Michael Lingley, Andrew Simor, Samira Mubareka, Sigmund Krajden, Larissa Matukas, Sharon Walmsley, Medina Saffie, Daniel Ricciuto, Krystyna Ostrowska, David Richardson, Shannon N Pyra, Joslyn D Gray

• July 7, 2026

Measles-Containing Vaccine Use for Children Aged 12 to 47 Months, 2015 to 2025

• by Meaghan S. Fagalde, Libby C. Page, Ellyn P. Marder, M. Mia Shim, Sharon Bogan, Disha Patel, Meagan K. Kay, Eric J. Chow

• July 10, 2026

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

• by Kathryn Wighton

• June 18, 2026

• 2 min